[
The retail portion of the issue was subscribed by 90%, while the issue was subscribed by 1.94 times in the non-institutional investors category on the first day of bidding. Meanwhile, the qualified institutional buyers had not made any bids yet.
The issue comprises a fresh issuance of 42.04 lakh shares worth Rs 50.02 crore and an offer for sale (OFS) of 19.99 lakh shares totaling Rs 23.79 crore.
Shri Ahimsa Naturals IPO’s GMP on Day 1
Ahead of listing, the company’s shares were trading with a GMP of Rs 10 in the unlisted market on Tuesday, indicating an 8.4% premium over the upper end of the IPO price band of Rs 119.
Price band for the IPO
The price band for Shri Ahimsa Naturals’ IPO has been set at Rs 113 to Rs 119 per share.
Proceeds from IPO
The company plans to use Rs 35 crore out of the total proceeds of IPO for investment in its wholly-owned subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for setting up a new manufacturing unit at Sawarda, Jaipur, Rajasthan. It will also use proceeds towards general corporate purposes, the details of which are not disclosed in the RHP.
Key dates for Shri Ahimsa Naturals IPO
The IPO will end on Thursday, March 27. The tentative allotment date is Friday, March 28, 2025 while the initiation of refunds will likely be on April 1. The credit of shares to the demat account is expected to be on the same day with listing likely on April 2.
About Shri Ahimsa Naturals IPO
The company will issue a total of 6,202,800 equity shares out of which, 42,03,600 Equity Share will be fresh while up to 19,99,200 equity shares will be offered for sale (OFS). The shares will be offered by promoter selling shareholders Nemi Chand Jain and Sumitra Jain.
The lot size will be 1,200 equity shares and in multiples thereof and investors can subscribe a minimum of 1 lot.
The maximum subscription amount for retail investors will be Rs 2 lakh. The maximum bid quantity for QIB investors is 41,36,400 equity shares in multiple of 1,200 equity shares while for NIB investors’ category 29,66,400 equity shares.
About company
The company primarily processes crude caffeine procured from multiple decaffeination plants. The primary raw material is crude caffeine, a bi-product of such decaffeination plants. We process crude caffeine to manufacture Green Coffee Beans Extracts (GCE) and Caffeine Anhydrous Natural. The company’s business is focused on extraction, manufacturing & sale of Caffeine Anhydrous Natural.
Anchor Allocation
The company has raised Rs 20.83 crore from seven investors which include Founders Collective Fund, Bharat Venture Opportunities Fund, Wealthwave Capital Trust-Wealthwave Capital Fund, Nav Capital Vcc – Nav Capital Emerging Star Fund, Milky Investment And Trading Company, Minerva Emerging Opportunities Fund Limited and Saint Capital Fund.
Promoters
The company’s promoters are Nemi Chand Jain, Sumitra Jain, Amit Kumar Jain, Sumit Jain, Prerna Jain, Ahimsa Holdings Private Limited and Bimneer Investments Private Limited.
Company’s financial information
The total consolidated income from operations in the six-month ended September 30, 2024 stood at Rs 40.71 crore while in the financial year ended March 31, 2024 it stood at Rs 77.97 crore. The net profit after tax and extraordinary items in the said periods stood at Rs 9.74 crore and Rs 18.66 crore in the respective periods.
Also read | Zepto in talks for $250 million secondary sale ahead of IPO
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
https://img.etimg.com/thumb/msid-119472134,width-1200,height-630,imgsize-34074,overlay-etmarkets/articleshow.jpg
https://economictimes.indiatimes.com/markets/ipos/fpos/shri-ahimsa-naturals-ipo-subscribed-31-so-far-on-day-1-check-gmp-price-band-and-other-details/articleshow/119472119.cms
